134 related articles for article (PubMed ID: 11887858)
21. Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis.
Pawlaczyk K; Kuzlan-Pawlaczyk M; Anderstam B; Heimbürger O; Bergström J; Waniewski J; Breborowicz A; Lindholm B
Nephrol Dial Transplant; 2001 Mar; 16(3):669-71. PubMed ID: 11239065
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum.
Margetts PJ; Kolb M; Yu L; Hoff CM; Holmes CJ; Anthony DC; Gauldie J
Am J Pathol; 2002 Jun; 160(6):2285-94. PubMed ID: 12057931
[TBL] [Abstract][Full Text] [Related]
23. Intraperitoneal hyaluronan administration in conscious rats: absorption, metabolism, and effects on peritoneal fluid dynamics.
Breborowicz A; Polubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Moberly J; Martis L; Oreopoulos D
Perit Dial Int; 2001; 21(2):130-5. PubMed ID: 11330555
[TBL] [Abstract][Full Text] [Related]
24. A pyruvate-buffered dialysis fluid induces less peritoneal angiogenesis and fibrosis than a conventional solution.
van Westrhenen R; Zweers MM; Kunne C; de Waart DR; van der Wal AC; Krediet RT
Perit Dial Int; 2008; 28(5):487-96. PubMed ID: 18708542
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions.
Cooker LA; Luneburg P; Holmes CJ; Jones S; Topley N;
Perit Dial Int; 2001; 21 Suppl 3():S102-7. PubMed ID: 11887802
[TBL] [Abstract][Full Text] [Related]
26. Biocompatibility of peritoneal dialysis fluids: long-term exposure of nonuremic rats.
Musi B; Braide M; Carlsson O; Wieslander A; Albrektsson A; Ketteler M; Westenfeld R; Floege J; Rippe B
Perit Dial Int; 2004; 24(1):37-47. PubMed ID: 15104335
[TBL] [Abstract][Full Text] [Related]
27. Comparison of three chronic dialysis models.
Peng WX; Guo QY; Liu SM; Liu CZ; Lindholm B; Wang T
Adv Perit Dial; 2000; 16():51-4. PubMed ID: 11045261
[TBL] [Abstract][Full Text] [Related]
28. Chronic infusion of sterile peritoneal dialysis solution abrogates enhanced peritoneal gene expression responses to chronic peritoneal catheter presence.
Zakaria el R; Matheson PJ; Hurt RT; Garrison RN
Adv Perit Dial; 2008; 24():7-15. PubMed ID: 18985994
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the biocompatibility of phosphate-buffered saline alone, phosphate-buffered saline supplemented with glucose, and dianeal 3.86%.
Wieczorowska-Tobis K; Styszynski A; Breborowicz A; Oreopoulos DG
Perit Dial Int; 2001; 21 Suppl 3():S362-4. PubMed ID: 11887856
[TBL] [Abstract][Full Text] [Related]
30. The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?
Nessim SJ; Perl J; Bargman JM
Kidney Int; 2010 Jul; 78(1):23-8. PubMed ID: 20336052
[TBL] [Abstract][Full Text] [Related]
31. Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.
Zareie M; van Lambalgen AA; ter Wee PM; Hekking LH; Keuning ED; Schadee-Eestermans IL; Faict D; Degréve B; Tangelder GJ; Beelen RH; van den Born J
Perit Dial Int; 2005; 25(1):58-67. PubMed ID: 15770927
[TBL] [Abstract][Full Text] [Related]
32. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.
Stompór T; Zdzienicka A; Motyka M; Dembińska-Kieć A; Davies SJ; Sulowicz W
Perit Dial Int; 2002; 22(6):670-6. PubMed ID: 12556068
[TBL] [Abstract][Full Text] [Related]
33. Effects of intraperitoneal hyaluronan on peritoneal fluid and solute transport in peritoneal dialysis patients.
Moberly JB; Sorkin M; Kucharski A; Ogle K; Mongoven J; Skoufos L; Lin L; Bailey S; Rodela H; Mupas L; Walele A; Ogrinc F; White D; Wolfson M; Martis L; Breborowicz A; Oreopoulos DG
Perit Dial Int; 2003; 23(1):63-73. PubMed ID: 12691509
[TBL] [Abstract][Full Text] [Related]
34. Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model.
Zheng Z; Ye R; Yu X; Bergström J; Lindholm B
Adv Perit Dial; 2001; 17():53-7. PubMed ID: 11510297
[TBL] [Abstract][Full Text] [Related]
35. Daily exposure to dialysis fluid results in changes in peritoneal transport.
Wang T; Qureshi AR; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Perit Dial Int; 1997; 17(4):379-86. PubMed ID: 9284466
[TBL] [Abstract][Full Text] [Related]
36. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
[TBL] [Abstract][Full Text] [Related]
37. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats.
Wieczorowska-Tobis K; Polubinska A; Schaub TP; Schilling H; Wisniewska J; Witowski J; Passlick-Deetjen J; Breborowicz A
Perit Dial Int; 2001; 21 Suppl 3():S108-13. PubMed ID: 11887803
[TBL] [Abstract][Full Text] [Related]
38. The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis.
Pawlaczyk K; Garcia-Lopez E; Kuzlan-Pawlaczyk M; Heimbürger O; Bergström J; Breborowicz A; Lindholm B
Perit Dial Int; 2001; 21 Suppl 3():S359-61. PubMed ID: 11887855
[TBL] [Abstract][Full Text] [Related]
39. The effects of a dialysis solution with a combination of glycerol/amino acids/dextrose on the peritoneal membrane in chronic renal failure.
de Graaff M; Zegwaard AH; Zweers MM; Vlijm A; de Waart DR; Vandemaele F; Struijk DG; Krediet RT
Perit Dial Int; 2010; 30(2):192-200. PubMed ID: 20124192
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronan preserves peritoneal membrane transport properties.
Guo QY; Peng WX; Cheng HH; Ye RG; Lindholm B; Wang T
Perit Dial Int; 2001; 21(2):136-42. PubMed ID: 11330556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
